FDA
-
-
-
-
-
-
-
60 Degrees Pharma gets safety board clearance for babesiosis trial
-
-
-
-
-
-
-
60 Degrees Pharma makes malaria drug available on telehealth platform
-
-
-
-
-
-
-
60 Degrees Pharmaceuticals partners with GoodRx for ARAKODA discounts
-
-
-
-
-
-
-
60 Degrees Pharmaceuticals, Inc. Announces Approval of Reverse Stock Split Ratio
-
-
-
-
-
-
-
60 Degrees Pharmaceuticals Announces Third Quarter 2025 Results
-
-
-
-
-
-
-
60 Degrees Pharmaceuticals Selects Icahn School of Medicine at Mount Sinai as Central Clinical Trial Site for Phase II Study to Evaluate Tafenoquine for Chronic Babesiosis
-
-
-
-
-
-
-
60 Degrees Pharmaceuticals Announces Pricing of Up to $10 Million Public Offering
-
329,618 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

